Buscar
01/05/2024
Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness
Ruiz-Ramos, J, López-Vinardell, L, Higa-Sansone, L, Torrecilla-Vall-LLossera, B, Puig-Campmany, M, Mangues-Bafalluy, MA, Juanes-Borrego, A. Anticholinergic burden and revisit risk in frail patients with pharmacological sleepiness. EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2024; 31(3)DOI:10.1136/ejhpharm-2022-003424. PMID:36100370. IF:1.500(Q4/8D).
01/05/2024
Analysis of the queries received on an antidote management online platform
Pi-Sala, N, Aguilar-Salmerón, R, Gispert-Ametller, MA, de Gamarra-Martínez, EF, García-Peláez, M, Martínez-Sánchez, L, Salgado-Garcia, E, Nogué-Xarau, S. Analysis of the queries received on an antidote management online platform. CLINICAL TOXICOLOGY. 2024; 62DOI:. PMID:. IF:3.300(Q2/4D).
01/05/2024
Analysis of intoxications that required the activation of an online platform to ensure antidote availability
Pi-Sala, N, de Gamarra-Martínez, EF, Aguilar-Salmerón, R, Gispert-Ametller, MA, Martínez-Sánchez, L, García-Peláez, M, Salgado-Garcia, E, Nogué-Xarau, S. Analysis of intoxications that required the activation of an online platform to ensure antidote availability. CLINICAL TOXICOLOGY. 2024; 62DOI:. PMID:. IF:3.300(Q2/4D).
01/05/2024
Drainage setons for the management of sinus tracts in hidradenitis suppurativa.
Vilarrasa E, Camiña-Conforto G, Cabo F, Fernández-Vela J, Pousa M, Romaní J. Drainage setons for the management of sinus tracts in hidradenitis suppurativa.. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2024; 90(5)DOI:10.1016/j.jaad.2023.08.058. PMID:37634739. IF:11.800(Q1/1D).
01/05/2024
Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists
Vilarrasa, E, Rivera, R, Eiris, N, Carretero, G, de la Cueva, P, Carrascosa, JM. Approach to the Epidemiology, Disease Management, and Current Challenges in the Management of Generalized Pustular Psoriasis Through a Survey Conducted Among Spanish Dermatologists. Actas Dermo-Sifiliograficas. 2024; 115(5)DOI:10.1016/j.ad.2023.10.022. PMID:37925068. IF:(Q/D).
01/05/2024
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study
Pinter, A, Soliman, AM, Pivneva, I, Ghanbariamin, R, Yang, M, Truong, B, Puig, L, Lebwohl, M. Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study. Dermatology and Therapy. 2024; 14(5)DOI:10.1007/s13555-024-01164-6. PMID:38727996. IF:4.200(Q1/1D).
01/05/2024
Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan
Tada, Y, Soliman, AM, Ishii, K, Sakuma, R, Pinter, A, Davis, M, Nunag, D, Buessing, M, Puig, L, Imafuku, S. Dose escalation of biologic treatment in patients with moderate-to-severe psoriasis in Japan. EXPERIMENTAL DERMATOLOGY. 2024; 33(5)DOI:10.1111/exd.15067. PMID:38757460. IF:3.100(Q2/3D).
01/05/2024
2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?
Gatica-Ortega, ME, Pastor-Nieto, MA, Giménez-Arnau, AM, Mercader-García, P, Sanz-Sánchez, T, Carrascosa-Carrillo, JM, Córdoba-Guijarro, S, Sánchez-Pérez, J, Silvestre, JF, Frutos, FJOD, Tous-Romero, F, Fernández-Redondo, V, Serra-Baldrich, E, Ruíz-González, I, Pérez, RG, Miquel-Miquel, J, Guillén, PSP, Hervella-García, M, Heras-Mendaza, F, Gómez-de-la-Fuente, E, Zaragoza-Ninet, V, Gilo, AS, Rodríguez-Serna, M, Melé-Ninot, G, Descalzo, MA, de-Vega, M, García-Doval, I, Borrego, L. 2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?. CONTACT DERMATITIS. 2024; 90(5)DOI:10.1111/cod.14520. PMID:38351475. IF:4.600(Q1/1D).